How to use TrumpRx to find cheaper cash prices on medications

[aggregator] downloaded image for imported item #36232

This post was originally published on this site.

Following last week’s launch of TrumpRx, a federal government-basedprescription drug platform, doctors are speaking about its potential benefits for consumers — and also its limitations.

The platform, which can be accessed atTrumpRx.gov, allows patients to access “large discounts on many of the most popular and highest-priced medicines in the country,” according to the statement on The White House website.

The goal is for consumers to get the lowest available pricing among other developed nations, referred to as the most-favored-nation (MFN) price.

TRUMP UNVEILS TRUMPRX TO OFFER DISCOUNTED PRESCRIPTION DRUGS

As of its initial launch, TrumpRx includes discounted pricing for 40 medications from five pharmaceutical manufacturers: AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer.

President Donald Trump makes announcement about TrumpRx.gov prescription website, Thursday, Feb. 5, 2026, at the White House in Washington, D.C.

President Donald Trump makes an announcement about the TrumpRx.gov prescription website on Thursday, Feb.5, 2026, at the White House in Washington, D.C.

“Depending on the manufacturer of agiven drug, patients with valid prescriptions will be able to access savings through user-friendly coupons that can be printed or downloaded onto their phones or through channels set up by the manufacturer and integrated into TrumpRx.gov,” the announcement says.

TrumpRx is not an online pharmacy, as it does not directly prescribe, dispense or sell medications.

Physicians’ perspectives

Dr.Brett Osborn, a Florida neurosurgeon and longevity expert, said he considers TrumpRx to be a “solid concept,” putting cheaper, cash-pay drug prices at the forefront. 

“Prescription drugs are one of the quiet ways families get squeezed every month,�“Anything that makes prices clearer and pushes them down is a step in the right direction.”

OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT-LOSS DRUGS FOR 4 KEY REASONS

Dr.�a step in the right direction.”

“We have a lack of price transparency in the system — drugmakers and pharmacy benefit managers jack up the prices, whichinsurance companiespay, but then transfer the cost to the consumer in terms of higher premiums, copays and deductibles,�

TrumpRx.gov website screen

As of its initial launch, TrumpRx includes discounted pricing for 40 medications from five pharmaceutical manufacturers.(Getty Images)

The goal of Trump Rx, according to Siegel, is not to enact government price controls, but to increase consumer choices, allowing them to pay directly for drugs in amounts that do not exceed what other countries are paying.

“TrumpRx will help provide access to crucial drugs that are otherwise not affordable or not covered by insurance, such asfertility drugs, cancer drugs, the growing GLP-1 market, diabetes drugs and asthma drugs,” Siegel said. 

WHAT ARE GLP-3S?MEET THE NEW GENERATION OF WEIGHT-LOSS DRUGS WITH THREE KEY INGREDIENTS

“Even with discounts offered through TrumpRx or through its partnership with GoodRx — where you go from Trump Rx to an online pharmacy (with a prescription) or to the manufacturer — these drugs are still expensive,” he added. 

What’s included

This first iteration of the marketplace focuses on several key medications, which means not all patients will find what they need.For now, TrumpRx focuses on anti-obesity(weight-loss) drugslike GLP-1 agonists — although Osborn said that is “exactly where national attention should be.”

“Obesity is not a cosmetic issue — it’s a metabolic epidemic, a gateway disease that underpins heart disease, stroke, diabetes, certain cancers, dementia and massive downstream health spending,” he said. 

“Anything that makes prices clearer and pushes them down is a step in the right direction.”

On TrumpRx, injectable Ozempic and Wegovy (for diabetes and obesity, respectively), could cost about $350 per month on average, down from ~$1,000+, with some doses as low as $199/month.Wegovy pillscould be as low as $149/month.

The price of Zepbound, Eli Lilly’s obesity medication, could fall to about $346 per month on average, or as low as $299 depending on the dose.

Commonly used medications for infertility, COPD, asthma, dermatitis, hot flashes and osteoporosis are also included.

Woman looking at pill labels next to her computer

The goal of Trump Rx, according to one doctor, is not to enact government price controls, but to increase consumer choices, allowing them to pay directly for drugs in amounts that do not exceed what other countries are paying.(iStock)

Osborn commended the platform for “not trying to be everything.”

“A moredirected platform– like TrumpRx — that highlights medications that address ‘root cause’ diseases sends a MAHA signal,” he said.“It shows people what matters.”

TRUMP ROLLS OUT ‘GREAT HEALTHCARE PLAN,’ URGES CONGRESS TO SLASH COSTS FOR AMERICANS

Novo Nordisk, maker of Ozempic and Wegovy, applaudedthe launch of the platform.

“We’re continuing to make it easier for people to access our authentic, FDA-approved medicines by expanding availability through multiple, convenient options,” said Chris Pernie, associate vice president of U.S.public affairs, referencing NovoCare Pharmacy, the company’s direct-to-patient channel that launched in March 2025.

“The launch of TrumpRx will further extend patients’ reach to Ozempic and Wegovy, including the newly approved Wegovy pill, at our self-pay prices,�

Limits and caveats

Osborn cautioned that some drugs may not always be cheaper than insurance once deductibles are met. 

“Cash payments (accessed through the platform’s coupons) do not count toward out-of-pocket limits,” he pointed out.“And comparing TrumpRx prices to list prices can make discounts on the site look bigger than they really are.”

A pharmacy tech pulls medication from a shelf inside a pharmacy

Health officials are working to secure more agreements with pharmaceutical companies to expand the selection of prescription drugs on the platform, The White House has stated.(George Frey/Bloomberg via Getty Images)

In anew commentary, Cato health policy expert Dr.Jeffrey Singer acknowledged that direct-to-consumer drug sales can help push prices down, but suggested that the federal government’s control of the system could pose a risk.

onelink.me/xLDS?pid=AppArticleLink&af_web_dp=https%3A%2F%2Fwww.

“President Trump is right that direct-to-consumer drug sales can restore cost sensitivity and put pressure on prices,” Singer wrote.“But agovernment-run platformrisks crowding out private competition and reintroducing political favoritism into a market that was already becoming more consumer-driven.”

Woman on her computer shopping for prescriptions

“A more directed platform – like TrumpRx — that highlights medications that address ‘root cause’ diseases sends a MAHA signal,” one doctor said.(iStock)

Siegel also pointed out that there is some concern about the impact on pharmaceutical research and development, “at a time of great innovation and personalized solutions.”

“Blood pressure control is non-negotiable.Controlblood pressure, blood sugar, lipids, body composition and lifestyle, and health follows,” he said.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top